In March 2025, the company introduced new ideas for just a direct-to-consumer providing of its Wegovy weight loss drug. The company recognized a completely new pharmacy, termed NovoCare, which would cost shoppers $499 every month for access to the drug, fewer than fifty percent the price of the drug by other pharmaceutical distribution networks.[53